The NHS is set to roll out a single, long-lasting injection this autumn to protect premature and vulnerable babies from respiratory syncytial virus (RSV). The jab offers a vital “protective bubble” ...

A single, long-lasting jab that offers a “protective bubble” to premature babies from a common virus is set to be rolled out on the NHS in England this autumn. Experts say the drug will give thousands ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...

Vaccination of pregnant women has been linked to a drop in newborns being admitted to hospital with a serious lung infection, ...

John C. Hu, MD, PhD, clinical assistant professor of medicine in the Division of Infectious Diseases in the Jacobs School of Medicine and Biomedical Sciences, is a co-senior author on a recently ...

Adults over 50 and those with chronic conditions are at risk too. Learn how to protect yourself and where to go for more information.

New research from the Children’s Hospital of Philadelphia shows the challenges of getting families to accept a promising new ...

Common cold coronavirus incidence decreased by more than half after widespread SARS-CoV-2 infections and vaccination compared ...

The FDA has accepted for review the sBLA to expand the indication of Arexvy (RSV vaccine, adjuvanted) to adults aged 18 to 49 years who are at increased risk.

Hospital readmission risk in pediatric patients was higher in those who were first admitted for RSV than in those who were first admitted for influenza or hMPV.

Vaccination of pregnant women int he UK has been linked to a drop in newborns being admitted to hospital with a serious lung infection, research suggests.

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...